133 related articles for article (PubMed ID: 29555153)
1. Synthesis and activity of functionalizable derivatives of the serotonin (5-HT) 5-HT
Gilbertson SR; Chen YC; Soto CA; Yang Y; Rice KC; Cunningham KA; Anastasio NC
Bioorg Med Chem Lett; 2018 May; 28(8):1381-1385. PubMed ID: 29555153
[TBL] [Abstract][Full Text] [Related]
2. Novel Bivalent 5-HT
Soto CA; Shashack MJ; Fox RG; Bubar MJ; Rice KC; Watson CS; Cunningham KA; Gilbertson SR; Anastasio NC
ACS Chem Neurosci; 2018 Mar; 9(3):514-521. PubMed ID: 29111677
[TBL] [Abstract][Full Text] [Related]
3. 5-HT2A receptor antagonist M100907 reduces serotonin synthesis: an autoradiographic study.
Hasegawa S; Fikre-Merid M; Diksic M
Brain Res Bull; 2012 Jan; 87(1):44-9. PubMed ID: 22056993
[TBL] [Abstract][Full Text] [Related]
4. Antagonizing 5-HT₂A receptors with M100907 and stimulating 5-HT₂C receptors with Ro60-0175 blocks cocaine-induced locomotion and zif268 mRNA expression in Sprague-Dawley rats.
Burton CL; Rizos Z; Diwan M; Nobrega JN; Fletcher PJ
Behav Brain Res; 2013 Mar; 240():171-81. PubMed ID: 23201361
[TBL] [Abstract][Full Text] [Related]
5. Reduced cortical serotonin 5-HT
Mora S; Merchán A; Vilchez O; Aznar S; Klein AB; Ultved L; Campa L; Suñol C; Flores P; Moreno M
Neuropharmacology; 2018 Dec; 143():10-19. PubMed ID: 30201211
[TBL] [Abstract][Full Text] [Related]
6. The adrenergic receptor antagonist carvedilol interacts with serotonin 2A receptors both in vitro and in vivo.
Murnane KS; Guner OF; Bowen JP; Rambacher KM; Moniri NH; Murphy TJ; Daphney CM; Oppong-Damoah A; Rice KC
Pharmacol Biochem Behav; 2019 Jun; 181():37-45. PubMed ID: 30998954
[TBL] [Abstract][Full Text] [Related]
7. [Synthesis and biological activities of new 5-HT2A selective ligands--N-substituted-piperidinyl-4-phenylthioether and sulfone derivatives].
Wang H; Wen R; Huang L; Bi R; Tan PZ
Yao Xue Xue Bao; 2001 Apr; 36(4):274-7. PubMed ID: 12580055
[TBL] [Abstract][Full Text] [Related]
8. Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement.
Fletcher PJ; Rizos Z; Noble K; Soko AD; Silenieks LB; Lê AD; Higgins GA
Neuropharmacology; 2012 Jun; 62(7):2288-98. PubMed ID: 22342986
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel potent and selective ligands for 5-HT2A receptor with quinazoline scaffold.
Deng X; Guo L; Xu L; Zhen X; Yu K; Zhao W; Fu W
Bioorg Med Chem Lett; 2015 Sep; 25(18):3970-4. PubMed ID: 26227779
[TBL] [Abstract][Full Text] [Related]
10. Serotonin (5-HT) 5-HT2A Receptor (5-HT2AR):5-HT2CR Imbalance in Medial Prefrontal Cortex Associates with Motor Impulsivity.
Anastasio NC; Stutz SJ; Fink LH; Swinford-Jackson SE; Sears RM; DiLeone RJ; Rice KC; Moeller FG; Cunningham KA
ACS Chem Neurosci; 2015 Jul; 6(7):1248-58. PubMed ID: 26120876
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment.
Zaniewska M; McCreary AC; Wydra K; Filip M
Synapse; 2010 Jul; 64(7):511-9. PubMed ID: 20196140
[TBL] [Abstract][Full Text] [Related]
12. Reverse microdialysis of a 5-HT2A receptor antagonist alters extracellular glutamate levels in the striatum of the MPTP mouse model of Parkinson's disease.
Ferguson MC; Nayyar T; Ansah TA
Neurochem Int; 2014 May; 71():36-46. PubMed ID: 24704796
[TBL] [Abstract][Full Text] [Related]
13. A practical synthesis of the serotonin 5-HT2A receptor antagonist MDL 100907, its enantiomer and their 3-phenolic derivatives as precursors for [11C]labeled PET ligands.
Ullrich T; Rice KC
Bioorg Med Chem; 2000 Oct; 8(10):2427-32. PubMed ID: 11058037
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, and Pharmacological Characterization of Heterobivalent Ligands for the Putative 5-HT
Poulie CBM; Liu N; Jensen AA; Bunch L
J Med Chem; 2020 Sep; 63(17):9928-9949. PubMed ID: 32815361
[TBL] [Abstract][Full Text] [Related]
15. Effects of 5-HT
Fletcher PJ; Zeeb FD; Browne CJ; Higgins GA; Soko AD
Psychopharmacology (Berl); 2017 Mar; 234(5):889-902. PubMed ID: 28097374
[TBL] [Abstract][Full Text] [Related]
16. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats.
Varty GB; Bakshi VP; Geyer MA
Neuropsychopharmacology; 1999 Apr; 20(4):311-21. PubMed ID: 10088132
[TBL] [Abstract][Full Text] [Related]
17. Individual Differences in Impulsive Action Reflect Variation in the Cortical Serotonin 5-HT2A Receptor System.
Fink LH; Anastasio NC; Fox RG; Rice KC; Moeller FG; Cunningham KA
Neuropsychopharmacology; 2015 Jul; 40(8):1957-68. PubMed ID: 25666313
[TBL] [Abstract][Full Text] [Related]
18. Pimavanserin exhibits serotonin 5-HT
Muneta-Arrate I; Diez-Alarcia R; Horrillo I; Meana JJ
Eur Neuropsychopharmacol; 2020 Jul; 36():83-89. PubMed ID: 32517960
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding.
Fletcher PJ; Grottick AJ; Higgins GA
Neuropsychopharmacology; 2002 Oct; 27(4):576-86. PubMed ID: 12377394
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel arylpiperazine derivatives containing the imidazole core targeting 5-HT(2A) receptor and 5-HT transporter.
Seo HJ; Park EJ; Kim MJ; Kang SY; Lee SH; Kim HJ; Lee KN; Jung ME; Lee M; Kim MS; Son EJ; Park WK; Kim J; Lee J
J Med Chem; 2011 Sep; 54(18):6305-18. PubMed ID: 21823597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
